Contineum Therapeutics, Inc. Class A Common Stock (CTNM) EPS is -$1.94
Contineum Therapeutics, Inc. Class A Common Stock (CTNM) EPS is -$1.94 as of 2024-12-31. That figure is from Lician’s product cache for this healthcare name — not a placeholder and not copied across tickers.
Read the full CTNM research page for quote, filings, and the rest of the model. This satellite exists so “Contineum Therapeutics, Inc. Class A Common Stock EPS” can rank with the actual number, then send you to /stock/ctnm.